A&O Shearman advises Prosus on its investment in Alan

Listed on the Amsterdam Stock Exchange, Prosus is investing EUR400m as part of this round, completed alongside new and existing investors.

This transaction allows Prosus to strengthen its exposure to the healthtech sector, against a backdrop of rapid transformation of health services driven by artificial intelligence technologies. By relying on a platform combining insurance, prevention, and access to care, Prosus intends to support the development of next-generation health solutions, meeting growing demand for digital services in the medical and insurance sectors.

The funds raised will notably support Alan's international development and accelerate the rollout of its technology solutions. Founded in 2016, the company is part of this innovation momentum, with an established presence across several jurisdictions.

Completion of the transaction remains subject to obtaining French regulatory approvals.

The A&O Shearman team was led by Paris-based partner Alexandre Ancel, counsel Julie Parent, senior associate Astrid Achard-Hoffman, and associate Jérôme Païs on the corporate M&A aspects. 

Also involved were partner Florence Ninane, counsel Roxane Hicheri, and associate Victoire Sipp on the competition law aspects; partner Claire Toumieux, associates Naomi-Lan Leroy and Marie Chauvat on the employment law aspects; partner Dan Benguigui, counsel Charly Latil, and associate Pedro-Alejandro Hejoaka on the litigation aspects.

Partners Brice Henry and Mia Dassas, associates Maxence Kieken and Marina Valdez advised on the financial regulation and asset management aspects; partner Laurie-Anne Ancenys and senior associate Juliette Mazilier on the IT/Data aspects; partner Charles Tuffreau, senior associate Elise Romelly, and associate Léa Richier on the intellectual property aspects, as well as partner Romaric Lazerges and senior associate Vianney Leroux on the public law aspects. A&O Shearman's offices in Spain, Luxembourg and Belgium were also involved.